|
DNAL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62581059726108E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62747593179802E-12 |
| Normal-vs-Stage2 |
1.74750000025981E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.361870E-02 |
| Stage1-vs-Stage3 |
1.602590E-01 |
| Stage1-vs-Stage4 |
3.164500E-04 |
| Stage2-vs-Stage3 |
3.618700E-03 |
| Stage2-vs-Stage4 |
3.55530000000215E-05 |
| Stage3-vs-Stage4 |
5.628100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-16 |
| Normal-vs-AfricanAmerican |
1.98029999953775E-07 |
| Normal-vs-Asian |
3.33066907387547E-16 |
| Caucasian-vs-AfricanAmerican |
1.831420E-01 |
| Caucasian-vs-Asian |
4.336200E-01 |
| AfricanAmerican-vs-Asian |
1.264600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22044604925031E-16 |
| Normal-vs-Female |
1.62725388719309E-12 |
| Male-vs-Female |
1.733000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62592161956354E-12 |
| Normal-vs-Age(81-100Yrs) |
2.191000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.792200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.298400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.967800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.879600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.927000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.817000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.62010005200619E-09 |
| Classical-VS-Follicular |
2.703700E-03 |
| Classical-VS-Other |
4.398800E-01 |
| Classical-VS-Normal |
5.99520433297585E-15 |
| Tall-VS-Follicular |
6.81520395673374E-11 |
| Tall-VS-Other |
8.103700E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.210980E-01 |
| Follicular-VS-Normal |
4.02609945382437E-10 |
| Other-VS-Normal |
3.77400000000083E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.217280E-03 |
|
|
